DAFNA Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
140,847
-72,500
| -34% | -$723K | 0.39% | 47 |
|
|
2025
Q1 | $1.27M | Buy |
213,347
+25,000
| +13% | +$149K | 0.36% | 49 |
|
|
2024
Q4 | $1.45M | Buy |
188,347
+26,763
| +17% | +$206K | 0.37% | 47 |
|
|
2024
Q3 | $1.65M | Buy |
161,584
+17,224
| +12% | +$176K | 0.39% | 51 |
|
|
2024
Q2 | $2.14M | Buy |
144,360
+45,800
| +46% | +$680K | 0.51% | 42 |
|
|
2024
Q1 | $1.34M | Hold |
98,560
| – | – | 0.31% | 57 |
|
|
2023
Q4 | $1.08M | Hold |
98,560
| – | – | 0.26% | 60 |
|
|
2023
Q3 | $1.08M | Hold |
98,560
| – | – | 0.34% | 55 |
|
|
2023
Q2 | $1.3M | Hold |
98,560
| – | – | 0.36% | 48 |
|
|
2023
Q1 | $1.34M | Hold |
98,560
| – | – | 0.4% | 43 |
|
|
2022
Q4 | $1.92M | Buy |
98,560
+1,000
| +1% | +$19.5K | 0.54% | 47 |
|
|
2022
Q3 | $1.86M | Sell |
97,560
-7,738
| -7% | -$147K | 0.5% | 42 |
|
|
2022
Q2 | $2.17M | Buy |
105,298
+16,000
| +18% | +$330K | 0.59% | 43 |
|
|
2022
Q1 | $2.87M | Buy |
89,298
+35,208
| +65% | +$1.13M | 0.75% | 37 |
|
|
2021
Q4 | $2.52M | Sell |
54,090
-28,971
| -35% | -$1.35M | 0.63% | 36 |
|
|
2021
Q3 | $2.24M | Buy |
+83,061
| New | +$2.24M | 0.6% | 44 |
|